Pioneering enzymatic vitreolysis treatment for floaters

A 2007 scientific publication recently came to our attention, "Posterior vitreous detachment and pharmacologic vitreolysis: The New Era of enzymatic vitrectomy". It talked about the use of plasmin, a protease from the patient's own blood, as an adjunct 15 minutes prior to surgical vitrectomy to induce posterior vitreous detachment .

Due to the potential effect any such drug may have on floaters, we requested an interview one of the article authors, Dr. Manuel Jose Diaz-Llopis, Professor of Ophthalmology and Head of Ophthalmology at Faith Hospital and the University of Valencia, Spain. He informed us that he has been performing the treatment over the past 18 months including on 20 patients whose only eye problem was vitreous opactities. Read interview